Assessment and Management of Challenging BI-RADS Category 3 Mammographic Lesions

医学 双雷达 放射科 小心等待 恶性肿瘤 乳房成像 活检 分类 乳腺摄影术 前列腺癌 癌症 乳腺癌 病理 人工智能 内科学 计算机科学
作者
Aya Y. Michaels,Robyn L. Birdwell,Chris Chung,Elisabeth P. Frost,Catherine S. Giess
出处
期刊:Radiographics [Radiological Society of North America]
卷期号:36 (5): 1261-1272 被引量:29
标识
DOI:10.1148/rg.2016150231
摘要

Breast Imaging Reporting and Data System (BI-RADS) category 3 lesions are probably benign by definition and are recommended for short-interval follow-up after a diagnostic workup has been completed. Although the original lexicon-derived BI-RADS category 3 definition applied to lesions without prior imaging studies (when stability could not be determined), in clinical practice, many lesions with prior images may be assigned to BI-RADS category 3. Although the BI-RADS fifth edition specifically delineates lesions that are appropriate for categorization as probably benign, it also specifies that the interpreting radiologist may use his or her discretion and experience to justify a "watchful waiting" approach for lesions that do not meet established criteria. Examples of such lesions include evolving masses or calcifications suggestive of prior trauma and instances when stability cannot be ascertained because of image quality. Although interval change is an important feature of malignancy, many benign lesions also change over time; thus, use of prior imaging studies and ongoing imaging surveillance to demonstrate the evolution of a probably benign lesion is justified. Some examples of common pitfalls associated with inappropriate BI-RADS category 3 assessment include failure to use proper BI-RADS descriptors, failure to perform a complete diagnostic workup, and overreliance on negative ultrasonographic findings. When appropriately used, short-interval follow-up saves many patients from undergoing biopsy of benign lesions, without decreasing the rate of cancer detection. ©RSNA, 2016
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
JW完成签到,获得积分10
1秒前
mito完成签到,获得积分10
2秒前
lxy完成签到,获得积分10
3秒前
4秒前
4秒前
大胆妙松发布了新的文献求助10
5秒前
只影有你完成签到,获得积分10
5秒前
开心的小熊猫完成签到,获得积分10
5秒前
霸王爱吃面完成签到,获得积分10
6秒前
怡然的幻灵完成签到,获得积分10
7秒前
宇麦达发布了新的文献求助10
7秒前
Gloria的保镖完成签到 ,获得积分10
7秒前
所所应助跳跃的怀寒采纳,获得10
8秒前
zgy1106完成签到,获得积分10
8秒前
YY完成签到,获得积分10
11秒前
小斌发布了新的文献求助10
11秒前
Youngen完成签到,获得积分10
12秒前
Owen应助七月流火采纳,获得10
13秒前
13秒前
AoAoo完成签到,获得积分10
13秒前
lin完成签到,获得积分10
15秒前
mou完成签到,获得积分10
15秒前
公西翠萱完成签到,获得积分10
15秒前
天真的棉花糖完成签到 ,获得积分10
16秒前
16秒前
季然完成签到,获得积分10
16秒前
17秒前
小美完成签到 ,获得积分10
17秒前
sai完成签到,获得积分10
17秒前
bin_zhang完成签到,获得积分10
18秒前
baobaoxiong完成签到,获得积分10
18秒前
新野完成签到,获得积分10
19秒前
小斌完成签到,获得积分10
20秒前
哈牛柚子鹿完成签到,获得积分10
20秒前
W_G完成签到,获得积分10
20秒前
酷炫橘子完成签到,获得积分10
20秒前
舟遥遥完成签到,获得积分10
21秒前
贪玩亦云完成签到,获得积分10
21秒前
背后的惜珊完成签到 ,获得积分10
21秒前
危机的曼香完成签到,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
Signals, Systems, and Signal Processing 610
Research Methods for Business: A Skill Building Approach, 9th Edition 500
Research Methods for Applied Linguistics 500
Picture Books with Same-sex Parented Families Unintentional Censorship 444
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6414052
求助须知:如何正确求助?哪些是违规求助? 8232757
关于积分的说明 17477252
捐赠科研通 5466833
什么是DOI,文献DOI怎么找? 2888516
邀请新用户注册赠送积分活动 1865364
关于科研通互助平台的介绍 1703234